Literature DB >> 15199384

Long-term compliance and changes in plasma lipids, plant sterols and carotenoids in children and parents with FH consuming plant sterol ester-enriched spread.

A L Amundsen1, F Ntanios, N van der Put, L Ose.   

Abstract

OBJECTIVE: To study the compliance and changes in plasma lipids, plant sterols, fat-soluble vitamins and carotenoids in children and parents with familial hypercholesterolemia (FH) consuming a plant sterol ester-enriched (PSE) spread.
DESIGN: A 26-week open-label follow-up of children who had previously been studied in a controlled cross-over design. The parents were also included in the open-label arm of the study.
SETTING: Outpatient clinic for treatment of hyperlipidemia.
SUBJECTS: A total of 37 children (7-13 y) and 20 parents (32-51 y) diagnosed with 'definite' or 'possible' heterozygous FH. In all, 19 of the parents, but no children, used statins. All were patients at the Lipid Clinic, National Hospital in Oslo.
INTERVENTIONS: Subjects were recommended to eat 20 g/day of PSE spread as part of their lipid-lowering diet.
RESULTS: The mean intake of PSE spread was 13.7 and 16.5 g/days in the children and parents, respectively, corresponding to 1.2 and 1.5 g of plant sterols. Plasma total cholesterol decreased by 9.1% in both children (P<0.001) and parents (P=0.002). The corresponding decreases in LDL cholesterol were 11.4% (P<0.001) and 11.0% (P=0.012). Increases in serum lathosterol, campesterol and sitosterol, adjusted for total cholesterol, were observed in the children (31, 96, 48%, respectively, P<0.001) at the end of the controlled cross-over period. In the parents, serum campesterol and sitosterol, adjusted for total cholesterol, increased by 92 and 39%, respectively (P< 0.001). Lipid-adjusted serum alpha- and beta-carotene decreased by 17.4% (P=0.008) and 10.9% (P=0.018), respectively, in the children at the end of the controlled PSE period, but increased again during the follow-up. In the parents, serum alpha- and beta-carotene concentrations were unchanged, while serum lutein and lycopene decreased by 7.3% (P=0.037) and 14.6% (P=0.044), respectively.
CONCLUSIONS: Sustained efficacy of cholesterol reduction and long-term compliance of PSE intake were demonstrated in this study.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15199384     DOI: 10.1038/sj.ejcn.1602015

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  7 in total

Review 1.  Treatment of dyslipidemia in children and adolescents.

Authors:  Kathryn Wood Holmes; Peter Oscar Kwiterovich
Journal:  Curr Cardiol Rep       Date:  2005-11       Impact factor: 2.931

Review 2.  Hyperlipidaemia in paediatric patients: the role of lipid-lowering therapy in clinical practice.

Authors:  Anthony S Wierzbicki; Adie Viljoen
Journal:  Drug Saf       Date:  2010-02-01       Impact factor: 5.606

Review 3.  Rational approach to the treatment for heterozygous familial hypercholesterolemia in childhood and adolescence: a review.

Authors:  L Iughetti; B Predieri; F Balli; S Calandra
Journal:  J Endocrinol Invest       Date:  2007-09       Impact factor: 4.256

Review 4.  Dietary interventions (plant sterols, stanols, omega-3 fatty acids, soy protein and dietary fibers) for familial hypercholesterolaemia.

Authors:  Anita Malhotra; Nusrat Shafiq; Anjuman Arora; Meenu Singh; Rajendra Kumar; Samir Malhotra
Journal:  Cochrane Database Syst Rev       Date:  2014-06-10

5.  Effect of a plant sterol, fish oil and B vitamin combination on cardiovascular risk factors in hypercholesterolemic children and adolescents: a pilot study.

Authors:  Iveta Garaiova; Jana Muchová; Zuzana Nagyová; Csilla Mišľanová; Stanislav Oravec; Andrej Dukát; Duolao Wang; Sue F Plummer; Zdeňka Ďuračková
Journal:  Nutr J       Date:  2013-01-08       Impact factor: 3.271

Review 6.  Familial hypercholesterolemia: A review.

Authors:  Mithun J Varghese
Journal:  Ann Pediatr Cardiol       Date:  2014-05

7.  Phytosterol supplementation in the treatment of dyslipidemia in children and adolescents: a systematic review.

Authors:  Luisa Montone Mantovani; Camila Pugliese
Journal:  Rev Paul Pediatr       Date:  2020-11-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.